Search Results

Digital clinical diagnostics and diabetes home testing provider Digostics revealed the results from its ground-breaking gestational diabetes mellitus remote screening collaboration with University Hospital Southampton NHS Foundation Trust, a partnership that saw expectant mothers in Hampshire become the first globally to access the gold standard oral glucose tolerance test without needing to attend clinic.

Hospital for Special Surgery, the world’s leading academic medical center focused on musculoskeletal health, ranked no. 1 in orthopedics, has expanded its services on Long Island with a new location in Southampton.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that Dr. Mirella Spalluto of the University of Southampton today presented “Investigating the effects of AXL inhibition during respiratory viral infections” during the 6th Forum on Respiratory Infections in Glasgow, Scotland.

ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most advanced next generation pertussis vaccine announces positive primary data outcomes in the CHAMPION-1 clinical trial conducted at University Hospital Southampton (UK) and University of Oxford (UK).

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today cited positive reported outcomes from a study of UroShield® that was conducted at the University of Southampton in the United Kingdom.